PBLA logo

Panbela Therapeutics (PBLA) Shareholders Equity

Annual Shareholders Equity

-$4.71 M
+$3.34 M+41.48%

31 December 2023

PBLA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$18.17 M
-$7.60 M-71.92%

30 September 2024

PBLA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PBLA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--285.7%
3 y3 years-146.1%-277.9%
5 y5 years-440.1%-1411.8%

PBLA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-146.1%+41.5%-277.9%at low
5 y5 years-146.1%+41.5%-234.9%at low
alltimeall time-146.1%+41.5%-234.9%at low

Panbela Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
-$18.17 M(+71.9%)
June 2024
-
-$10.57 M(+231.7%)
Mar 2024
-
-$3.19 M(-32.4%)
Dec 2023
-$4.71 M(-41.5%)
-$4.71 M(+89.7%)
Sept 2023
-
-$2.48 M(-151.7%)
June 2023
-
$4.80 M(+89.4%)
Mar 2023
-
$2.54 M(-131.5%)
Dec 2022
-$8.05 M(-178.8%)
-$8.05 M(-2.8%)
Sept 2022
-
-$8.28 M(+71.1%)
June 2022
-
-$4.84 M(-173.5%)
Mar 2022
-
$6.58 M(-35.6%)
Dec 2021
$10.21 M(+20.9%)
$10.21 M(-24.1%)
Sept 2021
-
$13.46 M(+128.1%)
June 2021
-
$5.90 M(-22.2%)
Mar 2021
-
$7.58 M(-10.2%)
Dec 2020
$8.45 M(+510.0%)
$8.45 M(-11.5%)
Sept 2020
-
$9.55 M(+496.8%)
June 2020
-
$1.60 M(+121.0%)
Mar 2020
-
$724.00 K(-47.7%)
Dec 2019
$1.39 M(+416.8%)
$1.39 M(-42.0%)
Sept 2019
-
$2.39 M(-2141.9%)
June 2019
-
-$117.00 K(-80.1%)
Mar 2019
-
-$588.00 K(-319.4%)
Dec 2018
$268.00 K
$268.00 K(-149.4%)
DateAnnualQuarterly
Sept 2018
-
-$542.00 K(-592.7%)
June 2018
-
$110.00 K(-104.7%)
Mar 2018
-
-$2.32 M(-37.1%)
Dec 2017
-$3.69 M(-20.5%)
-$3.69 M(+75.8%)
Sept 2017
-
-$2.10 M(+119.8%)
June 2017
-
-$955.00 K(-382.5%)
Mar 2017
-
$338.00 K(-107.3%)
Dec 2016
-$4.64 M(+73.1%)
-$4.64 M(+32.4%)
Sept 2016
-
-$3.50 M(+32.8%)
June 2016
-
-$2.64 M(-24.7%)
Mar 2016
-
-$3.50 M(+30.7%)
Dec 2015
-$2.68 M(+103.7%)
-$2.68 M(+34.8%)
Sept 2015
-
-$1.99 M(+434.5%)
June 2015
-
-$372.10 K(+28.2%)
Mar 2015
-
-$290.30 K(-77.9%)
Dec 2014
-$1.32 M(+854.3%)
-$1.32 M(+250.0%)
Sept 2014
-
-$376.00 K(+30.2%)
June 2014
-
-$288.80 K(+20.3%)
Mar 2014
-
-$240.00 K(+74.0%)
Dec 2013
-$137.90 K(+238.0%)
-$137.90 K(+8.8%)
Sept 2013
-
-$126.70 K(+38.8%)
June 2013
-
-$91.30 K(+6.0%)
Mar 2013
-
-$86.10 K(+111.0%)
Dec 2012
-$40.80 K(-89.9%)
-$40.80 K
Dec 2011
-$405.00 K
-

FAQ

  • What is Panbela Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Panbela Therapeutics?
  • What is Panbela Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Panbela Therapeutics?
  • What is Panbela Therapeutics quarterly shareholders equity year-on-year change?

What is Panbela Therapeutics annual stockholders equity?

The current annual shareholders equity of PBLA is -$4.71 M

What is the all time high annual shareholders equity for Panbela Therapeutics?

Panbela Therapeutics all-time high annual stockholders equity is $10.21 M

What is Panbela Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of PBLA is -$18.17 M

What is the all time high quarterly shareholders equity for Panbela Therapeutics?

Panbela Therapeutics all-time high quarterly stockholders equity is $13.46 M

What is Panbela Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, PBLA quarterly stockholders equity has changed by -$13.46 M (-285.73%)